Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 17:18:15
271,45 DKK
Kurs
Kurs
-1,47%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
409,95 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 25.09.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12.11.2026 0 Monate | 12.11.2026 | 0 Monate | 271,45 305 | 271,45 | 305 | 12,359551 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 271,45 240 | 271,45 | 240 | 11,585927 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 271,45 240 | 271,45 | 240 | 11,585927 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.11.2026 0 Monate | 05.11.2026 | 0 Monate | 271,45 223 | 271,45 | 223 | 17,848591 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 04.11.2026 0 Monate | 04.11.2026 | 0 Monate | 271,45 275 | 271,45 | 275 | 1,307791 | JEFFERIES | ||
| Novo Nordisk AS | 04.11.2026 0 Monate | 04.11.2026 | 0 Monate | 271,45 275 | 271,45 | 275 | 1,307791 | JPMORGAN | ||
| Novo Nordisk AS | 04.11.2026 12 Monate | 04.11.2026 | 12 Monate | 271,45 304 | 271,45 | 304 | 11,991159 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.11.2026 0 Monate | 04.11.2026 | 0 Monate | 271,45 312 | 271,45 | 312 | 14,938294 | UBS | ||
| Novo Nordisk AS | 28.10.2026 0 Monate | 28.10.2026 | 0 Monate | 271,45 275 | 271,45 | 275 | 1,307791 | JPMORGAN | ||
| Novo Nordisk AS | 14.10.2026 0 Monate | 14.10.2026 | 0 Monate | 271,45 332 | 271,45 | 332 | 22,306134 | UBS | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 271,45 225 | 271,45 | 225 | 17,111807 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.10.2026 0 Monate | 05.10.2026 | 0 Monate | 271,45 275 | 271,45 | 275 | 1,307791 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 271,45 245 | 271,45 | 245 | 9,743968 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 271,45 245 | 271,45 | 245 | 9,743968 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 22.09.2026 12 Monate | 22.09.2026 | 12 Monate | 271,45 305 | 271,45 | 305 | 12,359551 | BERENBERG | ||
| Novo Nordisk AS | 21.09.2026 12 Monate | 21.09.2026 | 12 Monate | 271,45 285 | 271,45 | 285 | 4,991711 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 271,45 275 | 271,45 | 275 | 1,307791 | JPMORGAN | ||
| Novo Nordisk AS | 21.09.2026 12 Monate | 21.09.2026 | 12 Monate | 271,45 275 | 271,45 | 275 | 1,307791 | JEFFERIES | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 271,45 260 | 271,45 | 260 | 4,218088 | JPMORGAN | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 271,45 332 | 271,45 | 332 | 22,306134 | UBS | ||
| Novo Nordisk AS | 16.09.2026 0 Monate | 16.09.2026 | 0 Monate | 271,45 332 | 271,45 | 332 | 22,306134 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 271,45 265 | 271,45 | 265 | 2,376128 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.09.2026 12 Monate | 11.09.2026 | 12 Monate | 271,45 250 | 271,45 | 250 | 7,902008 | MORGAN STANLEY | ||
| Novo Nordisk AS | 07.09.2026 12 Monate | 07.09.2026 | 12 Monate | 271,45 300 | 271,45 | 300 | 10,517591 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 03.09.2026 0 Monate | 03.09.2026 | 0 Monate | 271,45 275 | 271,45 | 275 | 1,307791 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 271,45 265 | 271,45 | 265 | 2,376128 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 271,45 265 | 271,45 | 265 | 2,376128 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12 Monate | 12 Monate | 271,45 290 | 271,45 | 290 | 6,833671 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 24.08.2026 0 Monate | 24.08.2026 | 0 Monate | 271,45 275 | 271,45 | 275 | 1,307791 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 271,45 290 | 271,45 | 290 | 6,833671 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.08.2026 0 Monate | 11.08.2026 | 0 Monate | 271,45 305 | 271,45 | 305 | 12,359551 | BERENBERG | ||
| Novo Nordisk AS | 07.08.2026 0 Monate | 07.08.2026 | 0 Monate | 271,45 | 271,45 | -- | DZ BANK | |||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 271,45 285 | 271,45 | 285 | 4,991711 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 271,45 290 | 271,45 | 290 | 6,833671 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 271,45 200 | 271,45 | 200 | 26,321606 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 271,45 332 | 271,45 | 332 | 22,306134 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.08.2026 12 Monate | 05.08.2026 | 12 Monate | 271,45 310 | 271,45 | 310 | 14,20151 | BARCLAYS | ||
| Novo Nordisk AS | 04.08.2026 12 Monate | 04.08.2026 | 12 Monate | 271,45 285 | 271,45 | 285 | 4,991711 | JEFFERIES | ||
| Novo Nordisk AS | 04.08.2026 0 Monate | 04.08.2026 | 0 Monate | 271,45 332 | 271,45 | 332 | 22,306134 | UBS | ||
| Novo Nordisk AS | 31.07.2026 0 Monate | 31.07.2026 | 0 Monate | 271,45 250 | 271,45 | 250 | 7,902008 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 271,45 290 | 271,45 | 290 | 6,833671 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 271,45 332 | 271,45 | 332 | 22,306134 | UBS | ||
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 271,45 285 | 271,45 | 285 | 4,991711 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 271,45 250 | 271,45 | 250 | 7,902008 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 271,45 290 | 271,45 | 290 | 6,833671 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 271,45 325 | 271,45 | 325 | 19,72739 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 271,45 290 | 271,45 | 290 | 6,833671 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 271,45 250 | 271,45 | 250 | 7,902008 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 271,45 250 | 271,45 | 250 | 7,902008 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 271,45 305 | 271,45 | 305 | 12,359551 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 271,45 270 | 271,45 | 270 | 0,534168 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 271,45 290 | 271,45 | 290 | 6,833671 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 271,45 290 | 271,45 | 290 | 6,833671 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 271,45 300 | 271,45 | 300 | 10,517591 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 271,45 270 | 271,45 | 270 | 0,534168 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 271,45 175 | 271,45 | 175 | 35,531405 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 271,45 290 | 271,45 | 290 | 6,833671 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 271,45 290 | 271,45 | 290 | 6,833671 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 271,45 | 271,45 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 271,45 300 | 271,45 | 300 | 10,517591 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 271,45 332 | 271,45 | 332 | 22,306134 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 271,45 250 | 271,45 | 250 | 7,902008 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 271,45 263 | 271,45 | 263 | 3,112912 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 271,45 250 | 271,45 | 250 | 7,902008 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 271,45 175 | 271,45 | 175 | 35,531405 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 271,45 300 | 271,45 | 300 | 10,517591 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 271,45 250 | 271,45 | 250 | 7,902008 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 271,45 275 | 271,45 | 275 | 1,307791 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 271,45 270 | 271,45 | 270 | 0,534168 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 271,45 250 | 271,45 | 250 | 7,902008 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 271,45 270 | 271,45 | 270 | 0,534168 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 271,45 332 | 271,45 | 332 | 22,306134 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 271,45 270 | 271,45 | 270 | 0,534168 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 271,45 263 | 271,45 | 263 | 3,112912 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 271,45 270 | 271,45 | 270 | 0,534168 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 271,45 250 | 271,45 | 250 | 7,902008 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 271,45 275 | 271,45 | 275 | 1,307791 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 271,45 270 | 271,45 | 270 | 0,534168 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 271,45 250 | 271,45 | 250 | 7,902008 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 271,45 270 | 271,45 | 270 | 0,534168 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 271,45 270 | 271,45 | 270 | 0,534168 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 271,45 300 | 271,45 | 300 | 10,517591 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 271,45 250 | 271,45 | 250 | 7,902008 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 271,45 270 | 271,45 | 270 | 0,534168 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 271,45 260 | 271,45 | 260 | 4,218088 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 271,45 270 | 271,45 | 270 | 0,534168 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 271,45 270 | 271,45 | 270 | 0,534168 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 271,45 400 | 271,45 | 400 | 47,356788 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 271,45 250 | 271,45 | 250 | 7,902008 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 271,45 400 | 271,45 | 400 | 47,356788 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 271,45 332 | 271,45 | 332 | 22,306134 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 271,45 340 | 271,45 | 340 | 25,253269 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 271,45 275 | 271,45 | 275 | 1,307791 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 271,45 350 | 271,45 | 350 | 28,937189 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 271,45 340 | 271,45 | 340 | 25,253269 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 271,45 275 | 271,45 | 275 | 1,307791 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 271,45 250 | 271,45 | 250 | 7,902008 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 271,45 270 | 271,45 | 270 | 0,534168 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 271,45 340 | 271,45 | 340 | 25,253269 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 271,45 340 | 271,45 | 340 | 25,253269 | BARCLAYS |
News
Aktuell
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M